Progressive MS Alliance Industry Forum: Maximizing Collective Impact To Enable Drug Development

P. Zaratin, G. Comi, T. Coetzee, K. Ramsey, K. Smith, A. Thompson, M. Panzara

Research output: Contribution to journalShort survey

6 Citations (Scopus)

Abstract

The Progressive MS Alliance Industry Forum describes a new approach to address barriers to developing treatments for progressive multiple sclerosis (MS). This innovative model promises to facilitate robust collaboration between industry, academia, and patient organizations and accelerate research towards the overarching goal of developing safe and effective treatments for progressive MS.

Original languageEnglish
Pages (from-to)808-810
Number of pages3
JournalTrends in Pharmacological Sciences
Volume37
Issue number10
DOIs
Publication statusPublished - Oct 1 2016

Fingerprint

Multiple Sclerosis
Industry
Pharmaceutical Preparations
Therapeutics
Research

ASJC Scopus subject areas

  • Toxicology
  • Pharmacology

Cite this

Progressive MS Alliance Industry Forum : Maximizing Collective Impact To Enable Drug Development. / Zaratin, P.; Comi, G.; Coetzee, T.; Ramsey, K.; Smith, K.; Thompson, A.; Panzara, M.

In: Trends in Pharmacological Sciences, Vol. 37, No. 10, 01.10.2016, p. 808-810.

Research output: Contribution to journalShort survey

Zaratin, P. ; Comi, G. ; Coetzee, T. ; Ramsey, K. ; Smith, K. ; Thompson, A. ; Panzara, M. / Progressive MS Alliance Industry Forum : Maximizing Collective Impact To Enable Drug Development. In: Trends in Pharmacological Sciences. 2016 ; Vol. 37, No. 10. pp. 808-810.
@article{50bc45be91ac4d229eee51c2fd452fcd,
title = "Progressive MS Alliance Industry Forum: Maximizing Collective Impact To Enable Drug Development",
abstract = "The Progressive MS Alliance Industry Forum describes a new approach to address barriers to developing treatments for progressive multiple sclerosis (MS). This innovative model promises to facilitate robust collaboration between industry, academia, and patient organizations and accelerate research towards the overarching goal of developing safe and effective treatments for progressive MS.",
author = "P. Zaratin and G. Comi and T. Coetzee and K. Ramsey and K. Smith and A. Thompson and M. Panzara",
year = "2016",
month = "10",
day = "1",
doi = "10.1016/j.tips.2016.07.005",
language = "English",
volume = "37",
pages = "808--810",
journal = "Trends in Pharmacological Sciences",
issn = "0165-6147",
publisher = "Elsevier Limited",
number = "10",

}

TY - JOUR

T1 - Progressive MS Alliance Industry Forum

T2 - Maximizing Collective Impact To Enable Drug Development

AU - Zaratin, P.

AU - Comi, G.

AU - Coetzee, T.

AU - Ramsey, K.

AU - Smith, K.

AU - Thompson, A.

AU - Panzara, M.

PY - 2016/10/1

Y1 - 2016/10/1

N2 - The Progressive MS Alliance Industry Forum describes a new approach to address barriers to developing treatments for progressive multiple sclerosis (MS). This innovative model promises to facilitate robust collaboration between industry, academia, and patient organizations and accelerate research towards the overarching goal of developing safe and effective treatments for progressive MS.

AB - The Progressive MS Alliance Industry Forum describes a new approach to address barriers to developing treatments for progressive multiple sclerosis (MS). This innovative model promises to facilitate robust collaboration between industry, academia, and patient organizations and accelerate research towards the overarching goal of developing safe and effective treatments for progressive MS.

UR - http://www.scopus.com/inward/record.url?scp=84987909236&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84987909236&partnerID=8YFLogxK

U2 - 10.1016/j.tips.2016.07.005

DO - 10.1016/j.tips.2016.07.005

M3 - Short survey

AN - SCOPUS:84987909236

VL - 37

SP - 808

EP - 810

JO - Trends in Pharmacological Sciences

JF - Trends in Pharmacological Sciences

SN - 0165-6147

IS - 10

ER -